Login
Home
Charts
Search
Watchlist
Products

Aayush Wellness Ltd

AAYUSH·BSE
24.68-1.00%Wed, 23 Sept '26 15:50

Aayush Wellness Ltd

AAYUSH
BSE
24.68
-1.00%
|Wed, 23 Sept '26 15:50
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
120Cr
Close
Close Price
24.57
Industry
Industry
Trading
PE
Price To Earnings
27.92
PS
Price To Sales
0.72
Revenue
Revenue
166Cr
Rev Gr TTM
Revenue Growth TTM
95.50%
PAT Gr TTM
PAT Growth TTM
-0.47%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
00111426222340454833
Growth YoY
Revenue Growth YoY%
104.2179.573.7116.646.3
Expenses
ExpensesCr
00111325212239444832
Operating Profit
Operating ProfitCr
00011111001
OPM
OPM%
2.16.44.35.32.31.40.90.72.4
Other Income
Other IncomeCr
00000011111
Interest Expense
Interest ExpenseCr
00000000000
Depreciation
DepreciationCr
00000000000
PBT
PBTCr
00011111111
Tax
TaxCr
00000000000
PAT
PATCr
00011111111
Growth YoY
PAT Growth YoY%
3,533.3541.2364.031.5-3.7-48.622.4
NPM
NPM%
2.36.44.34.95.13.02.41.24.3
EPS
EPS
0.00.00.10.20.20.20.20.30.20.10.3
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
00111426222340454833
Growth YoY
Revenue Growth YoY%
104.2179.573.7116.646.3
Expenses
ExpensesCr
00111325212239444832
Operating Profit
Operating ProfitCr
00011111001
OPM
OPM%
2.16.44.35.32.31.40.90.72.4
Other Income
Other IncomeCr
00000011111
Interest Expense
Interest ExpenseCr
00000000000
Depreciation
DepreciationCr
00000000000
PBT
PBTCr
00011111111
Tax
TaxCr
00000000000
PAT
PATCr
00011111111
Growth YoY
PAT Growth YoY%
3,533.3541.2364.031.5-3.7-48.622.4
NPM
NPM%
2.36.44.34.95.13.02.41.24.3
EPS
EPS
0.00.00.10.20.20.20.20.30.20.10.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
173155166
Growth
Revenue Growth%
12,063.5112.095.5
Expenses
ExpensesCr
070154164
Operating Profit
Operating ProfitCr
0322
OPM
OPM%
59.44.51.21.3
Other Income
Other IncomeCr
0033
Interest Expense
Interest ExpenseCr
0000
Depreciation
DepreciationCr
0000
PBT
PBTCr
1345
Tax
TaxCr
0000
PAT
PATCr
1344
Growth
PAT Growth%
488.618.3-0.5
NPM
NPM%
94.84.62.62.5
EPS
EPS
0.10.70.80.9
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
173155166
Growth
Revenue Growth%
12,063.5112.095.5
Expenses
ExpensesCr
070154164
Operating Profit
Operating ProfitCr
0322
OPM
OPM%
59.44.51.21.3
Other Income
Other IncomeCr
0033
Interest Expense
Interest ExpenseCr
0000
Depreciation
DepreciationCr
0000
PBT
PBTCr
1345
Tax
TaxCr
0000
PAT
PATCr
1344
Growth
PAT Growth%
488.618.3-0.5
NPM
NPM%
94.84.62.62.5
EPS
EPS
0.10.70.80.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
355
Reserves
ReservesCr
237
Current Liabilities
Current LiabilitiesCr
001
Non Current Liabilities
Non Current LiabilitiesCr
005
Total Liabilities
Total LiabilitiesCr
5918
Current Assets
Current AssetsCr
117
Non Current Assets
Non Current AssetsCr
4710
Total Assets
Total AssetsCr
5918
Financial YearMar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
355
Reserves
ReservesCr
237
Current Liabilities
Current LiabilitiesCr
001
Non Current Liabilities
Non Current LiabilitiesCr
005
Total Liabilities
Total LiabilitiesCr
5918
Current Assets
Current AssetsCr
117
Non Current Assets
Non Current AssetsCr
4710
Total Assets
Total AssetsCr
5918

Cash Flow

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-10-5
Investing Cash Flow
Investing Cash FlowCr
003
Financing Cash Flow
Financing Cash FlowCr
005
Net Cash Flow
Net Cash FlowCr
-102
Free Cash Flow
Free Cash FlowCr
-10
CFO To PAT
CFO To PAT%
-99.311.3-136.4
CFO To EBITDA
CFO To EBITDA%
-158.611.4-296.7
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-10-5
Investing Cash Flow
Investing Cash FlowCr
003
Financing Cash Flow
Financing Cash FlowCr
005
Net Cash Flow
Net Cash FlowCr
-102
Free Cash Flow
Free Cash FlowCr
-10
CFO To PAT
CFO To PAT%
-99.311.3-136.4
CFO To EBITDA
CFO To EBITDA%
-158.611.4-296.7

Ratios

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
57273135120
Price To Earnings
Price To Earnings
99.981.333.827.9
Price To Sales
Price To Sales
95.03.70.90.7
Price To Book
Price To Book
11.633.011.09.8
EV To EBITDA
EV To EBITDA
159.281.675.059.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
99.26.1
OPM
OPM%
59.44.51.21.3
NPM
NPM%
94.84.62.62.5
ROCE
ROCE%
12.140.525.925.9
ROE
ROE%
11.640.632.532.5
ROA
ROA%
11.438.922.722.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
57273135120
Price To Earnings
Price To Earnings
99.981.333.827.9
Price To Sales
Price To Sales
95.03.70.90.7
Price To Book
Price To Book
11.633.011.09.8
EV To EBITDA
EV To EBITDA
159.281.675.059.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
99.26.1
OPM
OPM%
59.44.51.21.3
NPM
NPM%
94.84.62.62.5
ROCE
ROCE%
12.140.525.925.9
ROE
ROE%
11.640.632.532.5
ROA
ROA%
11.438.922.722.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Aayush Wellness is a health and wellness company built on a single, sweeping pivot - it was a Basmati rice exporter for decades until 2024, when it rebranded and redirected everything toward herbal alternatives, supplements, diagnostics and wellness services. The recurring approach is to spot a large, often troubled consumer habit - chewing tobacco, poor sleep, undiagnosed conditions - and offer an Indian-rooted, Ayurvedic-informed product or service that is easy to access and priced for mass adoption. # Business segments A single consumer health platform expressed through four product-and-service lines - a herbal alternative to tobacco, a growing shelf of nutraceutical gummies and tablets, a network of diagnostic kiosks and digital health tools, and an early-stage wellness tourism plan - all built on the same asset-light, omni-channel distribution logic. ## 1. Herbal Pan Masala: the legal alternative to a 46,000-crore habit **A tobacco-free, supari-free chew that mimics the taste of traditional pan masala and gutkha, sold in sachets at the same price point and the same kirana counters - a swap, not a sacrifice.** - **Designed for the 27.49-crore tobacco user base** - the product is formulated with Ayurvedic ingredients as a non-addictive, spit-free alternative, targeting the nearly 29% of smokeless tobacco users who already say they want to quit. - **Priced to remove the cost excuse** - launched at roughly Rs. 7 per serving and later extended with a Rs. 10 sachet in three flavours (Pan Masala, Gutka, and Tobacco+Pan Masala), so that switching does not stretch the daily wallet of a mass-market consumer. - **Sold where the old habit was bought** - offline distribution runs through general trade, kirana stores and pan shops, while online it sits on Flipkart and on Blinkit for rapid hyperlocal delivery, putting a safer option within the same reach as the original product. - **Regulatory crackdowns open the door** - when Maharashtra invoked the organised-crime act against illegal gutkha syndicates in mid-2026, the company flagged it as a direct growth lever that pushes consumers toward a legal, tobacco-free alternative and shrinks the unorganised competition. ## 2. Nutraceuticals: supplements built for India’s specific deficiencies **A portfolio of gummies, capsules and tablets that targets conditions with large, measurable prevalence - poor sleep, nutritional gaps, metabolic disorders - and reaches buyers through quick-commerce, marketplaces and the company’s own site.** - **Launched with a sleep problem half the country shares** - the first product, Dreamy Sleep Gummies, addressed the finding that 49% of Indians struggle to fall asleep at least three times a week, offering a convenient nutraceutical solution. - **Built outward from beauty to brain to blood sugar** - subsequent launches included Beauty Vitamins Gummies for skin and hair, Brain Fuel Capsules for cognition, Immunity Booster Tablets, Liver Detox Tablets, and Dia Shield Tablets for the 23-crore-plus Indians affected by metabolic conditions. - **Omni-channel from day one** - products are listed on Amazon.in with 24-48 hour delivery, on the company’s own direct-to-consumer website, on Blinkit for quick-commerce, and in offline retail stores, so the purchase path matches how urban India already shops. - **Export order validates the formulation** - a US$ 3 million order from a Singapore distributor, covering effervescent tablets, marine collagen, probiotics and super-greens powders, opened the door to a Southeast Asian supplements market projected to cross a billion dollars by 2033. ## 3. Preventive Healthcare Services: a diagnostic kiosk in every neighbourhood **Physical health centres built around an AI-enabled kiosk that runs 59 tests in under three minutes, backed by teleconsultation and a digital lab platform - healthcare delivery without the heavy hospital build.** - **The health ATM is the front door** - the first centre in Virar, Mumbai, houses a kiosk that screens blood, sugar, urine, haemoglobin, lipids, skin, eye and cancer risk test in 2-3 minutes, creates a digital health record and connects to a doctor via telemedicine, inspired by the E-Sanjeevani National Telemedicine Service. - **Services wrap around the kiosk** - each centre also offers online consultations, hospitalisation assistance, insurance claims processing, vaccinations, mental wellness programmes, home care coordination and patient transport, making it a one-stop primary-care touchpoint. - **Digital platforms extend the reach** - the “Aayush Health” app and “Aayush Labs” website add teleconsultation, home sample collection, digital prescriptions and ABHA ID creation, operating on an asset-light model with a central lab for quality control rather than a chain of owned labs. - **Equipment sourced through a joint venture, not built** - a lifetime agreement with Healthrashi Nextgen India gives Aayush access to AI kiosks, mobile clinics and automated diagnostic platforms at optimised cost, which it then deploys under its own brand without taking any equity stake in the supplier. ## 4. Wellness Tourism: a planned bet on India’s 21-billion-dollar retreat market **An approved but not-yet-operational plan to build wellness retreats offering yoga, Ayurveda and spa therapies, developed with government and private partners.** - **Board approval with a Rs. 30 crore envelope** - the diversification was greenlit in December 2024 with an investment plan spread over two years, targeting therapeutic yoga, guided meditation, Ayurvedic treatments, spa therapies and nutritional counselling. - **Partnership-led, not solo-built** - the company intends to work with government agencies, tourism promotion boards and private businesses to establish the centres, rather than acquiring and developing real estate entirely on its own. # Group structure and partners **A lean holding company with five wholly owned subsidiaries - most still nascent - and a partnership model that supplies the hardware and the last-mile reach without tying up capital in equity stakes.** - Five wholly owned subsidiaries sit under Aayush Wellness: Aayush Worldwide (exports), Aayush Healthsciences, Aayush Labs (diagnostics aggregator), Aayush Ventures (software) and Aayush International Pte. Ltd. in Singapore (Southeast Asian market entry) - though as of the latest filings, the first two had not yet generated any turnover. - The joint venture with Healthrashi Nextgen India supplies medical equipment - AI kiosks, mobile clinics, diagnostic platforms - under a lifetime agreement with no equity exchanged and no board seats, keeping the arrangement purely commercial. - The Blinkit partnership puts herbal pan masala and nutraceuticals onto a quick-commerce platform with zero shareholding on either side, adding hyperlocal delivery without building a logistics fleet.

Documents — Aayush Wellness Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/qdxc6wl2fs2ueqwdwa8zsh33.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/j7rc0oyqarbwsj205l5hhwyw.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/1olv77z3m3bo9sqv0x8pvasb.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/chqb8w4csn6jncd1wb0z0k7d.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/pk9g8oa1swrnv53h2rqo0rdu.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/nuuys4yy1qspxlucpdissdsd.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/jopdi9fdmu71wv8mlytjbde9.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/uyn1jyd2d9db0wo7mdsqvtxt.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/t7vp2wf777okz246xc31y94z.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/qkgp0ajn9loii4jksvxdqh7y.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/d1p7rtg73qn8rvpxtb8rpwwd.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/063ajktokx0fqjz5zt5ylzit.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/pgs9bkxmj63ikczdmaf9al03.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/f9hnorijl2mxtdea4it0iak0.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/t9eshb2a1xtzs7esjneafewo.pdf